Dual hybridisation analysis of these four c-MYC-amplified cases demonstrated that the magnitude of c-MYC copy number gain was higher in the radiogenic breast cancers compared with the sporadic cancers (Figure 5). The gene discussed is MYC; the disease is breast cancer.